Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463289 · ClinicalTrials.gov registry record · NA
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
A NA study of Type 2 Diabetes and Type 1 Diabetes, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05463289: Recruiting NA study of Type 2 Diabetes and Type 1 Diabetes, sponsored by Johns Hopkins University.
NCT05463289 is a NA study of Type 2 Diabetes and Type 1 Diabetes that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 500 participants, below the 3,922-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05463289, a NA study of Type 2 Diabetes and Type 1 Diabetes, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the autonomous AI system in detecting diabetic retinopathy from retinal images of youth with diabetes.
Primary Outcome
Equivalence in proportion screened for diabetic retinopathy of white and non-white youth with autonomous AI
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Point of Care Autonomous AI diabetic retinopathy exam
Study Locations (1)
Maryland
- Johns Hopkins Pediatric Diabetes Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT05463289 shows while recruiting
NCT05463289 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 3,922-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Point of Care Autonomous AI diabetic retinopathy exam is the first listed.
NCT05463289 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05463289 about?
NCT05463289 is a clinical study titled "ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2". The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the auton...
What is the current status of trial NCT05463289?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2022-07-11. Estimated completion is 2026-03-30.
What conditions does trial NCT05463289 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 1 Diabetes, Cystic Fibrosis-related Diabetes.
What interventions are being tested in trial NCT05463289?
The interventions under investigation include: Point of Care Autonomous AI diabetic retinopathy exam (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05463289?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463289 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05463289's enrollment target sits among peer trials
500 44th of 327 higher than 283 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI